Asian Activities Report for December 7, 2011: Great Wall Motors (HKG:2333) Receives EU Whole Vehicle Type Approval for Voleex C30 and Voleex C20R
Chevalier International Holdings Limited (HKG:0025) has entered into a letter of intent in relation to possible acquisitions of certain hot spring hotels in Japan. Chevalier International is principally engaged in construction and engineering, insurance and investment, property development and investment, food and beverages, and computer and information communication technology. The acquisition, if completed, will help Chevalier diversify its income stream and gain from the development of the Japanese tourism industry.
Daiichi Sankyo Co., Ltd (TYO:4568) advises that its subsidiary Ranbaxy Laboratories Ltd. (BOM:500359), India's largest pharmaceutical company, has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin, a cholesterol-reducing medicine, in the US market. Atorvastatin will provide a safe, effective, affordable and accessible alternative to Pfizer's (NYSE:PFE) cholesterol-lowering medication Lipitor, which generated total annual sales of US$7.89 billion in the US through September 2011.
Ranbaxy Laboratories Limited
Great Wall Motor
Daiichi Sankyo Company, Limited
Chevalier International Holdings Limited